RARE insiders

16 insiders have filed at RARE since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Kakkis Emil DPresident & CEO2.82M2.801%10 sells $12.8M
Kassberg Thomas RichardCbo & EVP264.7k0.263%4 sells $2.2M
Huang Dennis KarlSee Remarks124.7k0.124%
Pinion John RichardSee Remarks110.0k0.109%3 sells $1.1M
Harris ErikEVP & Chief Commercial Officer89.5k0.089%4 sells $1.4M
Horn HowardChief Financial Officer85.0k0.085%9 sells $1.2M
Crombez EricEVP And Chief Medical Officer76.3k0.076%7 sells $654k
Parschauer Karah HerdmanEVP And Chief Legal Officer66.8k0.066%9 sells $1.8M
Huizenga Theodore AlanSVP, Chief Accounting Officer48.7k0.048%11 sells $233k
Welch Daniel GDirector32.7k0.032%
Narachi MichaelDirector32.7k0.032%
Dunsire DeborahDirector30.8k0.031%
Fust Matthew KDirector25.9k0.026%3 sells $620k
Suliman ShehnaazDirector25.9k0.026%
Ray AmritDirector23.4k0.023%
Sanders Corazon (corsee) D.Director15.3k0.015%3 sells $185k

Full register at boothcheck.com/insiders/RARE. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

RARE institutional holders · RARE research report